Endocrine Flashcards

1
Q

cAMP

A

FSH, LH, ACTH, TSH, CRH, hCG, ADH (V2 receptor), MSH, PTH, calcitonin, GHRH, glucagon

“FLAT CHAMP”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

cGMP

A

ANP, NO “think vasodilators”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

IP3

A

GnRH, Oxytocin, ADH (V1 receptor), TRH “GOAT”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Steroid receptor (cytosolic)

A

Vitamin D, Estrogen, Testosterone, Cortisol, Aldosterone, Progesterone
“VET CAP”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Steroid receptor (nuclear)

A

T3/T4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Intrinsic tyrosine kinase (MAP kinase pathway)

A

Insulin, IGF-1, FGF, PDGF (think growth factors)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Receptor-associated tyrosine kinase (JAK/STAT pathway)

A

GH, prolactin (also cytokine Il-2)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

For the pituitary gland, what hormones is the alpha subunit common to?

A

TSH, LH, FSH, hCG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the four functions of T3?

A

4B’s: brain maturation, bone growth, increased basal metabolic rate, beta-adrenergic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Conn’s syndrome

A

primary hyperaldosteronism; caused by an aldosterone-secreting tumor –> hypertension, hypokalemia, metabolic alkalosis, and LOW plasma renin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is secondary hyperaldosteronism?

A

Kidney perception of low intravascular volume –> overactive renin-angiotensin system (HIGH plasma renin); due to renal artery stenosis, chronic renal failure, CHF, cirrhosis, or nephrotic syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is Waterhouse-Friderichsen syndrome?

A

acute primary adrenal insufficiency due to adrenal hemorrhage associated with N. meningitis septicemia, DIC, endotoxin shock

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

phenoxygbenzamine

A

nonselective, irreversible alpha-blocker; used for treatment of pheochromocytoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the five episodic hyperadrenergic symptoms of pheochromocytoma?

A

5 P’s: pressure (elevated), pain (headache), perspiration, palpitations (tachycardia), pallor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the rule of 10’s for pheochromocytoma?

A

10%: malignant, bilateral, extra-adrenal, calcify, kids, familial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Neuroblastoma

A

most common tumor of the adrenal medulla in children; HVA (breakdown of dopamine) is elevated in urine; overexpression of N-myc associated with rapid tumor progression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What are the features of cretinism?

A

pot-bellied, pale, puffy-faced child with protruding umbilicus and protuberant tongue (due to severe fetal hypothyroidism, lack of dietary iodine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is the action of insulin?

A

Binds insulin receptor (tyrosine kinase activity

Liver: increases glucose stored as glycogen

Muscle: increases glycogen and protein synthesis, K uptake

Fat: aids TG storage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is the clinical use and toxicities of insulin?

A

Type 1 and 2 DM, gestational diabetes, life-threatening hyperkalemia, stress-induced hyperglycemia

Toxicities: hypoglycemia, hypersensitivity reaction (very rare)

20
Q

What is the action of sulfonylureas?

A

Close K channel in the B-cell –> depolarizes –> triggering of insulin release via increased calcium influx

“Kicking the pancreas” to increase insulin output

21
Q

What are the clinical use and toxicities of sulfonylureas?

A

Clinical use: stimulate release of endogenous insulin in type 2 DM; requires some islet fxn, so useless in DM type 1.

Toxicities; first generation: disulfiram-like effects, second generation: hypoglycemia

22
Q

What is the action of biguanides (metformin)?

A

Decrease gluconeogenesis, increase glycolysis and increase peripheral insulin sensitivity

23
Q

What are the clinical use and toxicities of biguanides?

A

Clinical use: oral, can be used with pts w/out islet fxn

Toxicities: most grave adverse effect is lactic acidosis (contraindicated for those with renal failure)

24
Q

What is the action of glitazones/thiazolidinediones?

A

increase insulin sensitivity in peripheral tissue; binds to PPAR-gamma nuclear transcription regulator

25
What are the clinical use and toxicities of glitazones/TZDs?
Clinical use: used as monotherapy in type 2 DM or combined with other agents Toxicity: weight gain, edema, hepatotoxicity, CV toxicity
26
What is the action of alpha-glucosidase inhibitors?
inhibit intestinal brush border alpha-glucosides; delayed sugar hydrolysis and glucose absorption lead to decreased postprandial hyperglycemia
27
What are the clinical use and toxicities of alpha-glucosidase inhibitors?
Clinical use: monotherapy in type 2 DM or in combination with other agents Toxicities: GI disturbance
28
How are mimetics (pramlintide) used?
Action: decrease glucagon Clinical use: Type 2 DM Toxicities: hypoglycemia, nausea, diarrhea
29
How are GLP-1 analogs (exenatide) used?
Action: increased insulin, decreased glucagon release Clinical use: Type 2 DM Toxicities: nausea, vomiting, pancreatitis
30
Lispro
rapid acting insulin
31
Aspart
rapid acting insulin
32
NPH
intermediate acting insulin
33
Glargine
long acting insulin
34
Detemir
long acting insulin
35
Tolbutamide
first generation sulfonylurea
36
Chlorpropamide
first generation sulfonylurea
37
Glyburide
second generation sulfonylurea
38
Glimepiride
second generation sulfonylurea
39
Glipizide
second generation sulfonylurea
40
Pioglitazone
Glitazone/ TZD
41
Rosiglitazone
Glitazone/ TZD
42
Acarbose
alpha-glucosidase inhibitor
43
Miglitol
alpha-glucosidase inhibitor
44
Propylthiouracil, methimazole
Mechanism: inhibit organification of iodide and coupling of thyroid hormone synthesis. Propylthiouracil also decreases conversion of T4 to T3. Clinical use: hyperthyroidism Toxicity: skin rase, agranulocytosis (rare), aplastic anemia, methimazole (possible teratogen), hepatotoxicity (propylthiouracil)
45
Levothyroxine, trioodothyronine
Mechanism: thyroxine replacement Clinical use: hypothyroidism, myxedema Toxicity: tachycardia, heat intolerance, tremors, arrhythmias
46
demeclocycline
Mechanism: ADH antagonist (member of tetracycline) Clinical use: SIADH Toxicity: nephrogenic DI, photosensitivity, abnormalities of bone and teeth
47
glucocorticoids
Mechanism: decrease production of leukotrienes and prostaglandins by inhibiting phospholipase A2 and expression of cox-2 Clinical use: Addison's, inflammation, immune suppression, asthma Toxicities: Cushings syndrome, muscle wasting, thin skin, easy bruisability, osteoporosis, adrenocortical atrophy, peptic ulcer disease, diabetes, adrenal insufficiency when drug stopped after chronic use